Arbeu RM

Language: Spanish
References: 15
Page: 398-400
PDF size: 95.49 Kb.

REFERENCES

1. O'Neal MA. A review of women's neurology. Am J Med. 2018; 131 (7): 735-744.

2. Guanyabens-Busca N, Casado-Ruiz V, Gine-Serven E, Palomeras E, Muriana D, Boix-Quintana E et al. Encefalitis antirreceptor de NMDA. Diagnóstico y tratamiento precoz en pacientes con sintomatología psicótica aguda-subaguda. Rev Neurol. 2019; 68 (1): 18-22.

3. Dalmau J, Graus F. Antibody-mediated encephalitis. N Engl J Med. 2018; 378 (9): 840-851.

4. Titulaer MJ, McCracken L, Gabilondo I, Armangué T, Glaser C, Iizuka T et al. Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study. Lancet Neurol. 2013; 12 (2): 157-165.

5. Seki M, Suzuki S, Iizuka T, Shimizu T, Nihei Y, Suzuki N et al. Neurological response to early removal of ovarian teratoma in anti-NMDAR encephalitis. J Neurol Neurosurg Psychiatry. 2008; 79 (3): 324-326.

6. Armangue T, Leypoldt F, Málaga I, Raspall-Chaure M, Marti I, Nichter C et al. Herpes simplex virus encephalitis is a trigger of brain autoimmunity. Ann Neurol. 2014; 75 (2): 317-323.

7. Leypoldt F, Titulaer MJ, Aguilar E, Walther J, Bonstrup M, Havemeister S et al. Herpes simplex virus-1 encephalitis can trigger anti-NMDA receptor encephalitis: case report. Neurology. 2013; 81 (18): 1637-1639.

8. Hu X, Wang J, Dong W, Fang Q, Hu L, Liu C. A meta-analysis of polycystic ovary syndrome in women taking valproate for epilepsy. Epilepsy Res. 2011; 97 (1-2): 73-82.

9. Sahota P, Prabhakar S, Kharbanda PS, Bhansali A, Jain V, Das CP et al. Seizure type, antiepileptic drugs, and reproductive endocrine dysfunction in Indian women with epilepsy: a cross-sectional study. Epilepsia. 2008; 49 (12): 2069-2077.

10. Verrotti A, D'Egidio C, Mohn A, Coppola G, Parisi P, Chiarelli F. Antiepileptic drugs, sex hormones, and PCOS. Epilepsia. 2011; 52 (2): 199-211.

11. Bushnell C, Saposnik G. Evaluation and management of cerebral venous thrombosis. Continuum (Minneap Minn). 2014; 20 (2): 335-351.

12. Ruiz-Sandoval JL, Chiquete E, Bañuelos-Becerra LJ, Torres-Anguiano C, González-Padilla C, Arauz A et al. Cerebral venous thrombosis in a Mexican multicenter registry of acute cerebrovascular disease: the RENAMEVASC study. J Stroke Cerebrovasc Dis. 2012; 21 (5): 395-400.

13. van Vlijmen EF, Veeger NJ, Middeldorp S, Hamulyák K, Prins MH, Büller HR et al. Thrombotic risk during oral contraceptive use and pregnancy in women with factor V Leiden or prothrombin mutation: a rational approach to contraception. Blood. 2011; 118 (8): 2055-2061; quiz 2375.

14. Practice Committee of the American Society for Reproductive Medicine. Electronic address: ASRM@asrm.org; Practice Committee of the American Society for Reproductive Medicine. Combined hormonal contraception and the risk of venous thromboembolism: a guideline. Fertil Steril. 2017; 107 (1): 43-51.

15. Dulicek P, Ivanova E, Kostal M, Sadilek P, Beranek M, Zak P et al. Analysis of risk factors of stroke and venous thromboembolism in females with oral contraceptives use. Clin Appl Thromb Hemost. 2018; 24 (5): 797-802.